Literature DB >> 33030872

Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.

Erin M Cleary1, R Kate Byron, Katherine A Hinely, Allison W Talley, Maged M Costantine, Kara M Rood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33030872      PMCID: PMC7771390          DOI: 10.1097/AOG.0000000000004126

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


× No keyword cloud information.
  3 in total

Review 1.  Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.

Authors:  Marion A Coe; Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2019 Mar/Apr       Impact factor: 3.702

2.  Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.

Authors:  Erin M Cleary; R Kate Byron; Katherine A Hinely; Allison W Talley; Maged M Costantine; Kara M Rood
Journal:  Obstet Gynecol       Date:  2020-11       Impact factor: 7.623

3.  Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.

Authors:  Theresa Winhusen; Michelle Lofwall; Hendrée E Jones; Christine Wilder; Robert Lindblad; Davida M Schiff; Scott Wexelblatt; Stephanie Merhar; Sean M Murphy; Shelly F Greenfield; Mishka Terplan; Elisha M Wachman; Frankie Kropp; Jeff Theobald; Mitra Lewis; Abigail G Matthews; Connie Guille; Michael Silverstein; Carmen Rosa
Journal:  Contemp Clin Trials       Date:  2020-04-27       Impact factor: 2.226

  3 in total
  2 in total

1.  The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series.

Authors:  Caroline Shadowen; Frederick Gerard Moeller; Caitlin E Martin
Journal:  J Addict Med       Date:  2021 Jul-Aug 01       Impact factor: 3.702

2.  Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.

Authors:  Erin M Cleary; R Kate Byron; Katherine A Hinely; Allison W Talley; Maged M Costantine; Kara M Rood
Journal:  Obstet Gynecol       Date:  2020-11       Impact factor: 7.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.